KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Shares Outstanding (Diluted Average) (2016 - 2025)

Incyte's Shares Outstanding (Diluted Average) history spans 16 years, with the latest figure at $200.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 4.67% year-over-year to $200.7 million; the TTM value through Dec 2025 reached $200.7 million, down 4.67%, while the annual FY2025 figure was $200.7 million, 4.67% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $200.7 million in Q4 2025 per INCY's latest filing, roughly flat from $201.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $227.2 million in Q1 2024 to a low of $195.8 million in Q3 2024.
  • Average Shares Outstanding (Diluted Average) over 5 years is $216.8 million, with a median of $222.2 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Diluted Average): decreased 13.25% in 2024, then grew 2.85% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $222.1 million in 2021, then rose by 0.85% to $224.0 million in 2022, then grew by 0.88% to $225.9 million in 2023, then fell by 6.82% to $210.5 million in 2024, then fell by 4.67% to $200.7 million in 2025.
  • Per Business Quant, the three most recent readings for INCY's Shares Outstanding (Diluted Average) are $200.7 million (Q4 2025), $201.4 million (Q3 2025), and $198.7 million (Q2 2025).